Exploring Computational Protein Studies and Therapeutic Design for Alzheimer's Disease

This chapter details the speaker's journey from medicinal chemistry to protein studies, focusing on collaborative research with UCSF and the early exploration of the amyloid beta hypothesis in Alzheimer's disease. It delves into the importance of combining computational and experimental approaches, highlighting advancements in protein folding, the discovery of the alpha sheet structure, and the development of molecules targeting toxic oligomers for therapeutic design.